COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors

被引:0
|
作者
Joshua Elliott
Barbara Bodinier
Matthew Whitaker
Cyrille Delpierre
Roel Vermeulen
Ioanna Tzoulaki
Paul Elliott
Marc Chadeau-Hyam
机构
[1] Imperial College London,Department of Epidemiology and Biostatistics, School of Public Health
[2] St Mary’s Hospital,MRC Centre for Environment and Health
[3] Norfolk Place,UMR LEASP
[4] Imperial College,Department of Hygiene and Epidemiology
[5] Royal Surrey County Hospital,Institute for Risk Assessment Sciences (IRAS)
[6] Université de Toulouse III,undefined
[7] UPS,undefined
[8] Inserm,undefined
[9] University of Ioannina Medical School,undefined
[10] Utrecht University,undefined
来源
关键词
COVID-19 mortality; SARS-CoV-2; Prospective cohort; UK biobank; Risk factor;
D O I
暂无
中图分类号
学科分类号
摘要
Most studies of severe/fatal COVID-19 risk have used routine/hospitalisation data without detailed pre-morbid characterisation. Using the community-based UK Biobank cohort, we investigate risk factors for COVID-19 mortality in comparison with non-COVID-19 mortality. We investigated demographic, social (education, income, housing, employment), lifestyle (smoking, drinking, body mass index), biological (lipids, cystatin C, vitamin D), medical (comorbidities, medications) and environmental (air pollution) data from UK Biobank (N = 473,550) in relation to 459 COVID-19 and 2626 non-COVID-19 deaths to 21 September 2020. We used univariate, multivariable and penalised regression models. Age (OR = 2.76 [2.18–3.49] per S.D. [8.1 years], p = 2.6 × 10–17), male sex (OR = 1.47 [1.26–1.73], p = 1.3 × 10–6) and Black versus White ethnicity (OR = 1.21 [1.12–1.29], p = 3.0 × 10–7) were independently associated with and jointly explanatory of (area under receiver operating characteristic curve, AUC = 0.79) increased risk of COVID-19 mortality. In multivariable regression, alongside demographic covariates, being a healthcare worker, current smoker, having cardiovascular disease, hypertension, diabetes, autoimmune disease, and oral steroid use at enrolment were independently associated with COVID-19 mortality. Penalised regression models selected income, cardiovascular disease, hypertension, diabetes, cystatin C, and oral steroid use as jointly contributing to COVID-19 mortality risk; Black ethnicity, hypertension and oral steroid use contributed to COVID-19 but not non-COVID-19 mortality. Age, male sex and Black ethnicity, as well as comorbidities and oral steroid use at enrolment were associated with increased risk of COVID-19 death. Our results suggest that previously reported associations of COVID-19 mortality with body mass index, low vitamin D, air pollutants, renin–angiotensin–aldosterone system inhibitors may be explained by the aforementioned factors.
引用
收藏
页码:299 / 309
页数:10
相关论文
共 50 条
  • [11] Vitamin D and COVID-19 infection and mortality in UK Biobank
    Hastie, Claire E.
    Pell, Jill P.
    Sattar, Naveed
    EUROPEAN JOURNAL OF NUTRITION, 2021, 60 (01) : 545 - 548
  • [12] Smoking and COVID-19 Infection and Related Mortality: A Prospective Cohort Analysis of UK Biobank Data
    Prats-Uribe, Albert
    Xie, Junqing
    Prieto-Alhambra, Daniel
    Petersen, Irene
    CLINICAL EPIDEMIOLOGY, 2021, 13 : 357 - 365
  • [13] Machine learning approach to dynamic risk modeling of mortality in COVID-19: a UK Biobank study
    Mohammad A. Dabbah
    Angus B. Reed
    Adam T. C. Booth
    Arrash Yassaee
    Aleksa Despotovic
    Benjamin Klasmer
    Emily Binning
    Mert Aral
    David Plans
    Davide Morelli
    Alain B. Labrique
    Diwakar Mohan
    Scientific Reports, 11
  • [14] Machine learning approach to dynamic risk modeling of mortality in COVID-19: a UK Biobank study
    Dabbah, Mohammad A.
    Reed, Angus B.
    Booth, Adam T. C.
    Yassaee, Arrash
    Despotovic, Aleksa
    Klasmer, Benjamin
    Binning, Emily
    Aral, Mert
    Plans, David
    Morelli, Davide
    Labrique, Alain B.
    Mohan, Diwakar
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [15] ROLE OF HLA ON COVID-19 RISK AND OUTCOMES IN THE UK BIOBANK
    Chazara, Olympe
    O'Neill, Amanda
    Camacho, Niedzica
    Lythgow, Kieren
    Petrovski, Slave
    HLA, 2021, 97 (04) : 313 - 313
  • [16] Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank
    Wan, Eric Yuk Fai
    Mathur, Sukriti
    Zhang, Ran
    Yan, Vincent Ka Chun
    Lai, Francisco
    Chui, Celine
    Li, Xue
    Wong, Carlos King Ho
    Yiu, Kai Hang
    Chan, Esther Wai Yin
    Wong, Ian
    BRITISH JOURNAL OF GENERAL PRACTICE, 2023, 73
  • [17] Shift work is associated with increased risk of COVID-19: Findings from the UK Biobank cohort
    Fatima, Yaqoot
    Bucks, Romola S.
    Mamun, Abdullah A.
    Skinner, Isabelle
    Rosenzweig, Ivana
    Leschziner, Guy
    Skinner, Timothy C.
    JOURNAL OF SLEEP RESEARCH, 2021, 30 (05)
  • [18] Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank
    Wan, Eric Yuk Fai
    Mathur, Sukriti
    Zhang, Ran
    Yan, Vincent Ka Chun
    Lai, Francisco Tsz Tsun
    Chui, Celine Sze Ling
    Li, Xue
    Wong, Carlos King Ho
    Chan, Esther Wai Yin
    Yiu, Kai Hang
    Wong, Ian Chi Kei
    CARDIOVASCULAR RESEARCH, 2023, 119 (08) : 1718 - 1727
  • [19] Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis
    Yang, Huazhen
    Chen, Wenwen
    Hu, Yao
    Chen, Yilong
    Zeng, Yu
    Sun, Yajing
    Ying, Zhiye
    He, Junhui
    Qu, Yuanyuan
    Lu, Donghao
    Fang, Fang
    Valdimarsdottir, Unnur A.
    Song, Huan
    LANCET HEALTHY LONGEVITY, 2020, 1 (02): : E69 - E79
  • [20] Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
    McQueenie, Ross
    Foster, Hamish M. E.
    Jani, Bhautesh D.
    Katikireddi, Srinivasa Vittal
    Sattar, Naveed
    Pell, Jill P.
    Ho, Frederick K.
    Niedzwiedz, Claire L.
    Hastie, Claire E.
    Anderson, Jana
    Mark, Patrick B.
    Sullivan, Michael
    O'Donnell, Catherine A.
    Mair, Frances S.
    Nicholl, Barbara, I
    PLOS ONE, 2020, 15 (08):